State-of-the-Art Treatments in Oncology: Clinical Cases in Metastatic Breast Cancer
VOORHEES, N.J., Jan. 4, 2012 /PRNewswire/ — Metastatic breast cancer is an extremely challenging diagnosis. Fortunately, recent advances in treatment, including the development of novel targeted agents, have resulted in improvements in the management of this disease. Because of the rapidly changing treatment milieu for metastatic breast cancer, it is critically important for physicians to understand these most recent advances in treatment in order to optimally treat patients with this diagnosis.
To address the need for current education on metastatic breast cancer, RMEI, LLC and Albert Einstein College of Medicine are jointly sponsoring a complimentary continuing medical education virtual lecture and podcast titled State-of-the-Art Treatments in Oncology: Clinical Cases in Metastatic Breast Cancer. This activity is supported by an educational grant from Genentech BioOncology.
Stefan Gluck, MD, PhD of theUniversity of Miami Miller School Of Medicine serves as faculty for this activity.
Healthcare professionals can visit www.rmei.com/mbc354vl to access this activity.
RMEI is a medical education company that specializes in independent, continuing medical education designed for clinicians to improve and deliver quality medical care to patients. The goal of RMEI educational offerings is to promote continuous professional development and the improvement of health outcomes. RMEI works closely with medical experts to develop activities that improve diagnosis and treatment leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.
For other educational opportunities, please visit www.RMEI.com.